R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions (R-FACT)
Sponsor: Leiden University Medical Center
A observational or N/A phase clinical study on Hemolysis, this trial is completed. The trial is conducted by Leiden University Medical Center and has accumulated 11 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2022 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Dec 2021 — Jun 2022 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Leiden University Medical Center
- Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
For direct contact, visit the study record on ClinicalTrials.gov .